Analysis of Treatment Effects in Heart Failure Subgroups and Trial Outcomes

Exploring the complexities of subgroup analysis in heart failure trials, with a specific focus on the Paragon trial and the challenges of interpreting treatment effects across different subgroups. Insights are shared on the importance of strategic subgroup selection, drawing from experiences in trials like Deliver and comparing the impacts of SGLT2 inhibitors to traditional medications.